In good news, CAR-T cell therapy, an indigenous cancer treatment recently licenced by India's drug regulator, has resulted in the cure of a patient with cancer.
CAR-T cell therapies, dubbed ‘living drugs,’ involve extracting a patient’s T-cells, genetically modifying them to express Chimeric Antigen Receptors (CARs), specifically designed to recognise cancer cells and infusing them back into the patient.
Chimeric Antigen Receptors (CARs) have opened up an exciting new field of therapeutic advancements for rare and difficult-to-treat cancers, as they have the ability to deliver targeted therapies that can kill tumor cells.
Oncternal Therapeutics Inc. (ONCT) Presents New Preclinical Data from its anti-ROR1 Cell Therapy Collaboration with the Karolinska Institutet streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Oncternal Therapeutics Presents New Preclinical Data from its anti-ROR1 Cell Therapy Collaboration with the Karolinska Institutet at the EHA2022 Congress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.